DDrare: Database of Drug Development for Rare Diseases

Radiation: pet/ct scan: two pet scans using 1. c-11 hed and 2. n-13 ammonia or rubidium-82 (DrugBank: Ammonia, Rubidium)

告示番号	疾患名（ページ内リンク）	臨床試験数
86	肺動脈性肺高血圧症	1

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT03344159 (ClinicalTrials.gov)	April 1, 2018	28/9/2017	Spironolactone Therapy in Chronic Stable Right HF Trial	Spironolactone Therapy in Chronic Stable Right HF Trial	Chronic Right-Sided Heart Failure;Pulmonary Arterial Hypertension;Pulmonary Hypertension, Primary, 2;Pulmonary Hypertension, Primary, 3;Pulmonary Hypertension, Primary, 4;Cardiomyopathy Right Ventricular	Drug: Spironolactone;Drug: Placebo;Radiation: PET/CT Scan: Two PET scans using 1. C-11 HED and 2. N-13 Ammonia or rubidium-82;Diagnostic Test: Cardiac MRI (Gadolinium enhanced)	Ottawa Heart Institute Research Corporation	NULL	Suspended	18 Years	N/A	All	30	Phase 4	Canada

No.

TrialID

Date_
enrollment

Date_
registration

Public_title

Scientific_title

Condition

Intervention

Primary_
sponsor

Secondary_
sponsor

Recruitment_
Status

Inclusion_
agemin

Inclusion_
agemax

Inclusion_
gender

Target_
size

Phase

Countries

NCT03344159
(ClinicalTrials.gov)

April 1, 2018

28/9/2017

Spironolactone Therapy in Chronic Stable Right HF Trial

Chronic Right-Sided Heart Failure;Pulmonary Arterial Hypertension;Pulmonary Hypertension, Primary, 2;Pulmonary Hypertension, Primary, 3;Pulmonary Hypertension, Primary, 4;Cardiomyopathy Right Ventricular

Drug: Spironolactone;Drug: Placebo;Radiation: PET/CT Scan: Two PET scans using 1. C-11 HED and 2. N-13 Ammonia or rubidium-82;Diagnostic Test: Cardiac MRI (Gadolinium enhanced)

Ottawa Heart Institute Research Corporation

NULL

Suspended

18 Years

N/A

All

Phase 4

Canada